Concepedia

Author

Myriam Riek

Roche (Switzerland)

Also Known As

Myriam Riek

16

Publications

580

Citations

10

H-Index

15

Concepts

All Affiliations

Roche (Switzerland)SCQM FoundationLa Roche CollegeUniversity Hospital of GenevaUniversity Hospital of Zurich
MR

About

Myriam Riek is an author at Roche (Switzerland) specializing in pharmacokinetics, pharmacotherapy, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

187

2

Pharmacology

2

2

187

3

Health Sciences

1

1

67

4

Hepatology

1

1

67

5

Antimicrobial Pharmacokinetics

1

1

67

Myriam Riek

×

10

Publications

565

Citations

10

H-Index

YearCitations

The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition

Ashok Rakhit, Michael Pantze, Scott Fettner,

European Journal of Clinical Pharmacology

2007

120

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

Cem Gabay, Myriam Riek, Almut Scherer,

Lara D. Veeken

2015

94

Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals

Jie Ling, Scott Fettner, Bert L. Lum,

Anti-Cancer Drugs

2008

86

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Cem Gabay, Myriam Riek, Merete Lund Hetland,

Annals of the Rheumatic Diseases

2015

70

Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers

Christophe Schmitt, Myriam Riek, Katie Winters,

Archives of Drug Information

2009

67

Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis

Adrian Ciurea, Almut Scherer, Ulrich Weber,

Annals of the Rheumatic Diseases

2015

58

Effect of Saquinavir‐Ritonavir on Cytochrome P450 3A4 Activity in Healthy Volunteers Using Midazolam as a Probe

Christophe Schmitt, Carsten Hofmann, Myriam Riek,

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

2009

25

Saquinavir 500 mg Film-Coated Tablets Demonstrate Bioequivalence to Saquinavir 200 mg Hard Capsules When Boosted with Twice-Daily Ritonavir in Healthy Volunteers

Beate Bittner, Myriam Riek, Beverly Holmes,

Antiviral Therapy

2005

18

CLINICAL STUDY: Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate‐dependent HIV‐negative patients on stable methadone maintenance therapy

Candice Jamois, Patrick F. Smith, Royce A. Morrison,

Addiction Biology

2009

16

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases

Catherine Raptis, Christoph Berger, Adrian Ciurea,

Frontiers in Immunology

2022

11

Page 1